Primary biliary cirrhosis secondary prevention

Revision as of 20:21, 7 February 2018 by Anmol Pitliya (talk | contribs)
Jump to navigation Jump to search

Primary Biliary Cirrhosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Primary Biliary Cirrhosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Primary biliary cirrhosis secondary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Primary biliary cirrhosis secondary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Primary biliary cirrhosis secondary prevention

CDC on Primary biliary cirrhosis secondary prevention

Primary biliary cirrhosis secondary prevention in the news

Blogs on Primary biliary cirrhosis secondary prevention

Directions to Hospitals Treating Primary biliary cirrhosis

Risk calculators and risk factors for Primary biliary cirrhosis secondary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Dildar Hussain, MBBS [2]


Overview

Effective measures for the secondary prevention of primary biliary cirrhosis include follow up with liver function tests, thyroid status, upper GI endoscopy, bone mineral density, fat-soluble vitamin levels, ultrasound and alpha-fetoprotein levels to screen for hepatocellular carcinoma among aged men and patients with underlying cirrhosis.

Secondary Prevention

References

  1. Chazouillères O, Wendum D, Serfaty L, Rosmorduc O, Poupon R (2006). "Long term outcome and response to therapy of primary biliary cirrhosis-autoimmune hepatitis overlap syndrome". J. Hepatol. 44 (2): 400–6. doi:10.1016/j.jhep.2005.10.017. PMID 16356577.
  2. Poupon, Raoul; Chazouilleres, Olivier; Corpechot, Christophe; Chrétien, Yves (2006). "Development of autoimmune hepatitis in patients with typical primary biliary cirrhosis". Hepatology. 44 (1): 85–90. doi:10.1002/hep.21229. ISSN 0270-9139.
  3. Colombato LA, Alvarez F, Côté J, Huet PM (1994). "Autoimmune cholangiopathy: the result of consecutive primary biliary cirrhosis and autoimmune hepatitis?". Gastroenterology. 107 (6): 1839–43. PMID 7958699.
  4. Weyman RL, Voigt M (2001). "Consecutive occurrence of primary biliary cirrhosis and autoimmune hepatitis: a case report and review of the literature". Am. J. Gastroenterol. 96 (2): 585–7. doi:10.1111/j.1572-0241.2001.03562.x. PMID 11232713.

Template:WH Template:WS